Commission expenditure linked to pharmaceutical marketing income qualifies as business deduction when recipient identity, genuineness and business pur...
Country of Origin Certificates and declared transaction value supported preferential customs exemption where authenticity and invoice prices remained ...
Not accepting the revised return of income and disallowing the claim of loss - Submission of return for losses - there is no specific denial u/s 80 that the return filed u/s 139(3), which is considered the return filed u/s 139(1), cannot be revised u/s 139(5).
Not accepting the revised return of income and disallowing the claim of loss - Submission of return for losses - there is no specific denial u/s 80 that the return filed u/s 139(3), which is considered the return filed u/s 139(1), cannot be revised u/s 139(5).
Note: It is a system-generated summary and is for quick reference only.